Program Description: 

The Lung Cancer Conference is a multidisciplinary collaboration and communication between specialties to discuss lung cancer cases with adherence to the most up to date NCCN guidelines for appropriate diagnosis of patients, even in complex cases. With ever-evolving oncologic research, access to trials, genetic testing and updated NCCN guidelines, the need for collaborative providers and specialties to discuss complex classes and treatment protocols leads to the ability to develop a recommendation for current and future patient care in a holistic manner documented in the electronic health care record. Oncologic cases can be requested or submitted to the tumor board for review. For each case discussed the goal is to improve staging of patient disease, performance status, influence improved quality outcomes, understand and apply national treatment guidelines (NCCN) and current oncology standards of care to optimize the management of patients with lung cancer.

Key Words: Lung, Thoracic, Cancer, Diagnostic, Analytical

Target audience: 
  • Physicians
  • Nurse Practitioners
  • Physician Assistants
  • Nurses
  • Pharmacists
  • Social Workers
  • Genetic Counselors, Researchers, Physical Therapists
Learning objectives: 

Participants who engage in this educational intervention will be able to:

  • For cases discussed, improve staging of patient disease process, performance status in order to influence improved quality outcomes.
  • Identify and apply national treatment guidelines (NCCN) and current oncology standards of care to optimize the management of patients with lung cancer.
  • Communicate the importance of a multidisciplinary approach and improve the collaborative performance of the inter-professional oncology care team in the management of patients with cancer.
Faculty & credentials: 

Activity Director(s):

Harsha Poola, MD
Regional Cancer Center
ThedaCare
 
In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
  • Harsha Poola, MD 

The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.

NameCompanyRole
   
   

Contact

Name: 
Gina Durkee
Series date: 
01/01/2024 - 8:00am CST to 12/31/2024 - 11:59pm CST

The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.00 hours of participation for continuing education for allied health professionals.

 

Group description: 
ThedaCare Lung Cancer Conference 2024
Series location: 
Virtual Meeting
Milwaukee, WI
United States

Sessions

Session Date
Lung Cancer Conference 2024 01/08/2024 - 5:00pm to 6:00pm CST
Lung Cancer Conference 2024 01/22/2024 - 5:00pm to 6:00pm CST
Lung Cancer Conference 2024 02/05/2024 - 5:00pm to 6:00pm CST
Lung Cancer Conference 2024 02/19/2024 - 5:00pm to 6:00pm CST
Lung Cancer Conference 2024 03/04/2024 - 5:00pm to 6:00pm CST
Lung Cancer Conference 2024 03/18/2024 - 5:00pm to 6:00pm CDT
Lung Cancer Conference 2024 04/15/2024 - 5:00pm to 6:00pm CDT
Lung Cancer Conference 2024 04/29/2024 - 5:00pm to 6:00pm CDT
Lung Cancer Conference 2024 05/13/2024 - 5:00pm to 6:00pm CDT